Core Insights - The core insight of the article is that Novo Nordisk's weight loss drug Wegovy has shown strong initial demand in the U.S. market, with 3,071 prescriptions written in the first four days post-launch, indicating a potential competitive advantage over rivals like Eli Lilly [1] Group 1: Market Performance - Wegovy's oral tablet has achieved 3,071 prescriptions within the first four days of its U.S. launch, reflecting significant initial uptake [1] - The data shared by analysts only accounts for retail channel prescriptions and does not include those dispensed through Novo Nordisk's own NovoCare Pharmacy online channel, suggesting that the actual number of prescriptions could be higher [1] Group 2: Competitive Landscape - Investors are closely monitoring Novo Nordisk's ability to maintain its first-mover advantage in a highly competitive weight loss drug market [1] - The competitive dynamics are highlighted by the presence of other players like Eli Lilly, emphasizing the importance of Wegovy's market performance in sustaining its lead [1]

Group 1 - Alibaba-W (09988) increased by over 4.7% following the announcement of an investigation into the competitive landscape of the food delivery platform service industry by the State Council's Anti-Monopoly and Anti-Unfair Competition Committee [1] - Jiumaojiu (09922) rose nearly 3% after reporting a decline in same-store daily sales for its brands, with Taier, Songhuo Hotpot, and Jiumaojiu showing year-on-year decreases of 3.0%, 19.0%, and 16.4% respectively [2] - Xixiangfeng Group (02473) surged over 8% after announcing a strategic cooperation agreement with New Stone Technology, focusing on areas such as autonomous vehicle procurement and market promotion [3] - COSCO Shipping Energy (01138) increased by over 7.2% due to reports of the U.S. government's indefinite control over Venezuelan oil circulation and sales [4] Group 2 - Weilong Delicious (09985) rose over 2% as Goldman Sachs highlighted management's guidance for over 15% year-on-year revenue growth in FY2025, with a net profit margin between 18% and 20% [5] - Li Fu China (02136) surged by over 26.8% after announcing a board meeting to consider and approve the declaration of a special dividend to shareholders [6] - Kuaishou-W (01024) increased by over 5.8%, with a cumulative rise of over 20% in the month, driven by the popularity of its AI features on global social media platforms [7] - CATL (03750) fell nearly 3% as lithium carbonate prices surged past multiple thresholds, reaching 150,000 yuan per ton [8] Group 3 - Yidu Tech (02158) saw its stock price rise by over 8.8% after the approval of a key laboratory for the development of a multi-modal intelligent diagnosis and treatment system [9] - LFG Investment Holdings (03938) skyrocketed over 123.6% after announcing the transfer of 61.43% equity from its former major shareholder to an independent third party [10] Group 4 - Aktis Oncology (AKTS.US) debuted on the U.S. market with a rise of over 24.44%, focusing on developing alpha particle radiopharmaceuticals for common solid tumors [5] - Atlas Critical Minerals (ATCX.US) fell 41.33% after transitioning from OTCQB to NASDAQ, despite being an upgrade [6] - Critical Metals (CRML.US) rose 11.17%, with significant gains over the past week, driven by the approval of a new facility in Greenland [7] - Semiconductor equipment and materials stocks saw a broad increase, with ASML (ASML.US) reaching a historical high [8]

Core Viewpoint - Novo Nordisk (NVO.US) has launched the world's first oral GLP-1 medication for adult weight loss in the U.S., which is expected to enhance its market position and revenue potential [1] Group 1: Product Launch - The oral medication, Wegovy, is available in a starting dose of 1.5 mg [1] - Wegovy is now stocked in over 70,000 pharmacies across the U.S., including CVS and Costco [1] - Patients can purchase the starting dose at a price of $149 per month [1] Group 2: Market Impact - Following the announcement, Novo Nordisk's stock price increased by 4.4%, reaching $57.54 [1]

Policy Developments - The National Healthcare Security Administration is soliciting public opinions on the "Traditional Chinese Medicine Decoction Pieces Traceability Code Encoding Rules" to promote a unified traceability system for traditional Chinese medicine [1] - The National Medical Products Administration has released the "Internet Drug and Medical Device Information Service Filing Management Regulations," which will take effect immediately [2] Drug and Device Approvals - YHLO Biotech announced that it has received medical device registration certificates for two products from the Guangdong and Hunan Provincial Medical Products Administration [3] - Lianhuan Pharmaceutical reported that its raw material drug, Levonorgestrel, has passed pre-certification by the World Health Organization, although this will not significantly impact current operating performance [4] Capital Market Activities - Taiji Group plans to publicly transfer 40% of its stake in the subsidiary company Aida through a public listing, with an initial transfer price of 108,000 yuan [5] - Jiangsu Zhiyuan Pharmaceutical has completed nearly 300 million yuan in Pre-IPO financing, led by Innovation Works [6] Industry Developments - Tongxin Medical announced that its fully magnetic levitation artificial heart has completed enrollment of 100 patients in the INNOVATE clinical trial in the U.S. [7][8] - Novo Nordisk plans to launch the oral version of Wegovy in the U.S. in January 2026, marking it as the first oral GLP-1 drug for weight management [9] Public Sentiment - The Zhejiang Provincial Government has dispatched a working group to oversee the follow-up handling of a medical incident involving a child's postoperative death at Ningbo University Women's and Children's Hospital [10] Regulatory Actions - Haohai Biological Technology announced that its controlling shareholder, Jiang Wei, has been fined 14.63 million yuan by the China Securities Regulatory Commission for insider trading, which will not affect the company's daily operations [11]

Group 1: AI and Technology Developments - Fliggy's AI platform has integrated 214 large models, with token consumption increasing 20 times year-on-year and daily user calls rising 7.7 times [1] - The number of merchants using AI operational tools on the Fliggy platform has grown by 2.4 times year-on-year [1] - Nvidia is restructuring its cloud team by merging the existing cloud business team with engineering and operations departments [7] Group 2: Corporate Developments - Taiping Bird Group has established a new investment company in Hainan with a registered capital of 50 million RMB, focusing on asset management and investment activities [2] - Wuliangye Group has set up a supply chain management company in Hainan with a registered capital of 100 million RMB, involved in food sales and alcohol management [4] - USANA has appointed Wang Sheng as the president of its China region, effective immediately [3] Group 3: Market Trends and Financial Insights - Apple is significantly increasing its procurement of DRAM from Samsung, expecting Samsung to supply 60% to 70% of the DRAM for the iPhone 17 [6] - Saks Global is reportedly considering bankruptcy as it faces limited options before a debt deadline of over 100 million USD [6] - Guotou Securities forecasts a slight recovery in the performance growth of listed banks in 2026, with a focus on structural improvements in credit growth [11] Group 4: Investment and Financing - "Mianbi Intelligent" has completed a financing round of several hundred million RMB, with funds aimed at enhancing research and development of efficient large models [8] - "Obita" has completed a Pre-A round of financing, raising nearly 30 million USD in total across two rounds, with funds directed towards business development and global payment infrastructure [9] Group 5: New Product Launches - Weipai has launched the Blue Mountain intelligent advanced version, which is the world's first mass-produced vehicle equipped with the Yuanrong Qixing VLA model [10] - Zhiyu has released its next-generation flagship model GLM-4.7, enhancing capabilities in coding, long-term task planning, and collaborative tools [10] Group 6: Infrastructure and Industry Growth - As of November 2025, China's electric vehicle charging infrastructure has reached 19.322 million units, a year-on-year increase of 52%, with public charging facilities growing by 36% [13]

Core Viewpoint - Novo Nordisk's Wegovy oral tablet has received approval in the United States, marking it as the first oral GLP-1 medication for weight management. The company plans to launch the product in January 2026 [1]. Group 1 - Wegovy oral tablet demonstrates weight loss effects comparable to the Wegovy 2.4 mg injection [1]. - In the OASIS 4 trial, one in three participants experienced a weight loss of 20% or more [1].

Core Insights - Novo Nordisk announced that Wegovy oral tablets have been approved in the United States, marking the first oral GLP-1 medication for weight management [1] - The company plans to launch Wegovy oral tablets in the U.S. in January 2026 [1] - The weight loss effect of Wegovy oral tablets is comparable to that of the Wegovy 2.4mg injection [1] - In the OASIS4 trial, one in three participants experienced a weight loss of 20% or more [1]

Group 1 - Alphabet has agreed to acquire Intersect for $4.75 billion in cash, which will enhance its data center and energy infrastructure capabilities [2] - The acquisition allows Alphabet to explore emerging energy technologies to diversify its energy supply while supporting its data center investments in the U.S. [2] - The deal signifies a shift in focus for tech giants from merely stacking computing power to investing in energy infrastructure [2] Group 2 - Larry Ellison has provided an irrevocable personal guarantee of over $40 billion for Paramount's acquisition of Warner Bros. Discovery, addressing market concerns about the deal's uncertainty [3] - The guarantee ensures that Ellison's family trust will not be revoked or transferred unfavorably during the transaction [3] - Oracle's stock rose over 3% following the announcement of the personal guarantee [3] Group 3 - Novo Nordisk's Wegovy® oral tablets have been approved in the U.S., marking a significant breakthrough in the weight management drug market [4] - The oral formulation is expected to have similar weight loss effects as the injectable version, with one in three patients losing 20% or more of their body weight in trials [4] - The approval is anticipated to broaden the patient base and improve medication adherence [4] Group 4 - NVIDIA is reportedly restructuring its cloud team and shifting focus away from directly competing with Amazon Web Services (AWS) [5] - The company is merging its cloud business team with engineering and operations departments to prioritize internal chip demand over external sales [5] - This move indicates a return to NVIDIA's core hardware strategy rather than pursuing cloud service competition [5] Group 5 - NVIDIA aims to export H200 chips to China by mid-February, with initial shipments expected to be between 5,000 to 10,000 modules, corresponding to 40,000 to 80,000 chips [6] - The sales will be subject to U.S. government approval and security review, with a 25% fee on the transactions [6] - NVIDIA's efforts to adapt to international trade rules reflect its flexibility in navigating market conditions [6]

Market Trends - Precious metals continue to reach new highs, with COMEX gold futures rising by 2.13% to $4480.6 per ounce, and silver futures increasing by 2.37% to $69.09 per ounce. Platinum surged over 6% to break the $2100 per ounce mark, while palladium also saw significant gains [1] - The US stock market saw all three major indices close higher, with the S&P 500 up 0.64%, the Nasdaq up 0.52%, and the Dow Jones up 0.47%. The VIX index fell to 14.08, the lowest level since December 2024, driven by gains in AI-related stocks such as Nvidia and Tesla [1] Commodity Prices - WTI crude oil futures settled up 2.64% at $58.01 per barrel, while Brent crude rose 2.65% to $62.07 per barrel. Recent US actions in Venezuela have raised concerns about oil supply security [2] - Tungsten powder saw a weekly increase of approximately 18%, while silver prices have risen over 128% year-to-date, and palladium has increased by over 95% [1][2] Stock Market Activity - Southbound funds recorded a net purchase of approximately HKD 31.25 billion, with notable net buys in SMIC and Xiaomi, while China Mobile faced net selling [3] - Four new stocks listed on the Hong Kong market experienced significant declines on their first day, with losses ranging from 24.17% to 49.46% [3] Investment Trends - Insurance capital has shown increased enthusiasm for stock purchases, with a total of 39 instances of stake increases this year, primarily favoring high-dividend stocks in banking, infrastructure, and logistics sectors [3] - Stock ETFs have seen a net inflow of 400.96 million shares in December, with broad-based ETFs attracting over RMB 11.137 billion [4] Economic Policies - The Chinese government is planning to implement a series of major projects to stimulate economic growth and expand domestic demand, as discussed in a recent State Council meeting [10] - The National Healthcare Security Administration has initiated a centralized procurement process for high-value medical consumables, aiming to streamline costs and improve access [10] Industry Developments - A breakthrough in optical computing chips has been achieved by researchers at Shanghai Jiao Tong University, which could significantly impact the market for optical communication chips, projected to grow at a CAGR of 17% from 2025 to 2030 [8] - The global cloud infrastructure services spending is expected to reach $102.6 billion by Q3 2025, reflecting a 25% year-on-year growth, driven by the increasing demand for AI technologies [13] Company Announcements - Vanke has extended the grace period for a bond repayment from 5 working days to 30 trading days, although the revised repayment plan was not approved by bondholders [4] - Huaxia Happiness rejected proposals from Ping An Life to increase its stake, indicating ongoing governance challenges [14]